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a b s t r a c t
The work productivity loss due to ankylosing spondylitis (AS) has become subject of inter-
est because of its socioeconomic impact. In addition to physical limitations, other variables 
seem to affect the productivity of those patients, who often withdraw early from the labor 
force. This review was aimed at identifying articles published in English, from January 2001 
to December 2011, which assessed those variables in adult patients of both sexes diagnosed 
with AS, using standardized instruments to measure disease activity and work productiv-
ity. Thirty-three articles meeting the inclusion criteria were identifi ed. The work productiv-
ity loss of patients with AS proved to be infl uenced by demographics, emotional, social, 
cultural, and occupational factors, and lifestyle. Understanding those potential risk factors 
may contribute to the development of preventive strategies to maintain patients with AS 
participating in the labor force
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Variáveis relacionadas com perda da produtividade no trabalho em 
pacientes com espondilite anquilosante
Palavras-chave:
Espondilite anquilosante
Efi ciência
Trabalho
Fatores de risco
Revisão
r e s u m o
A perda da produtividade no trabalho, como resultado da espondilite anquilosante, tem 
se tornado tema de interesse dado o seu impacto socioeconômico. Além das limitações 
físicas, outras variáveis parecem interferir na produtividade desses pacientes que muitas 
vezes são aposentados precocemente do mercado de trabalho. Assim, esse manuscrito de 
revisão buscou identifi car artigos publicados na língua inglesa no período de janeiro de 
2001 a dezembro de 2011 que discutissem essas variáveis por meio de estudos realizados 
com pacientes adultos com diagnóstico de espondilite anquilosante, de ambos os gêneros 
e que usaram instrumentos padronizados para a avaliação da atividade da doença e da 
capacidade produtiva no trabalho. Foram identifi cados 33 artigos atendendo aos critérios 
de inclusão e observou-se que a perda de produtividade no trabalho em pacientes com 
espondilite anquilosante é infl uenciada por variáveis demográfi cas, emocionais, sociocul-
turais e ocupacionais, e hábitos de vida. Compreender esses possíveis fatores de risco pode 
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colaborar para a elaboração de estratégias preventivas para a manutenção de pacientes 
com espondilite anquilosante no mercado de trabalho.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Ankylosing spondylitis (AS) is a chronic infl ammatory dis-
ease that affects 0.1% to 1.4% of the general population, being 
characterized by the preferential involvement of the vertebral 
column and progressively impairing mobility and functional 
capacity.1,2 The disease has a relevant socioeconomic impact, 
because its major incidence is under the age of 40 years,3 lead-
ing to reduced working hours, missed professional opportuni-
ties, and early retirement.4 One of the major consequences of 
the disease is work productivity loss (WPL), which is mainly 
associated with physical limitation, chronic pain, impaired 
quality of life, poor self-esteem, and other emotional disor-
ders, such as anxious and depressed mood.5-8
In addition to physical limitations and aspects related to 
the AS itself, several other variables can infl uence WPL, such 
as demographics, emotional and socioeconomic factors, life 
habits, and work or occupational conditions. A better under-
standing of those possible risk factors might provide a more 
adequate elaboration of preventive strategies to keep patients 
with AS participating in the labor force.
Thus, this review study aimed at systematically compiling 
studies on WPL of patients with AS, in addition to identifying 
and discussing the major related aspects.
Methods
A systematic bibliographic survey was conducted in the 
PubMed database from January 2001 to December 2011, by 
using the search strategy of combining the descriptor “Anky-
losing Spondylitis” with the following descriptors: “Work In-
stability”; “Work Productivity”; “Work Disability”; and “Risk 
Factors”. 
Initially, 335 articles were identifi ed, of which, 33 met the 
inclusion criteria, which comprised studies published in 
English and performed on adult patients of both sexes diag-
nosed with AS. In addition, only studies using standardized 
tools validated for assessing their samples were selected, 
such as the following: BASDAI (Bath Ankylosing Spondylitis 
Disease Activity Index);9 BASFI (Bath Ankylosing Spondylitis 
Functional Index);10 HAQ-S (Health Assessment Question-
naire – Spondylitis);11 BASMI (Bath Ankylosing Spondylitis 
Mobility Index);12 AS-WIS (Work Instability Scale for Anky-
losing Spondylitis);13 WPAI-SHP (Work Productivity and Ac-
tivity Impairment Questionnaire: Specifi c Health Problem);14 
WPAI:SpA (Work Productivity and Activity Impairment ques-
tionnaire in AS);15 and WLQ (Work Limitations Question-
naire).16
All 33 full articles were read, their information summa-
rized, and the variables interfering with WPL were grouped 
into categories. 
Results
The prevalence of permanent work disability ranges from 
10% to 40%, depending on the disease stage, age at disease 
onset, and the characteristics of each country, such as pa-
tient’s access to the health care system.4,6,17-20 In the United 
States, the annual cost related to WPL is estimated at US$ 
5,000 for each patient with AS.5 Although the new modali-
ties of AS treatment contributed to reduce the impact of 
WPL21 over the past decade, some studies still show a high 
rate of withdrawal from work or early retirement of those 
patients22,23 and the existence of factors that can infl uence 
that phenomenon.
Table 1 summarizes the variables associated with the WPL 
of patients with AS reported in the articles reviewed. Those 
variables were subdivided according to risk and protection 
(Table 2).
Related to the disease itself
Activity and functionality
Most studies have shown a close correlation of WPL with 
higher disease activity, as well as with worse functionality17-28 
and worse mobility18,22,28 in patients with AS, according to the 
most commonly used instruments BASDAI,9 BASFI,10 HAQ-S11 
and BASMI.12
Table 1 – Variables associated with the WPL of patients 
with AS.
1. Related to the 
disease itself
1.1 Activity and functionality
1.2 Time since diagnosis
1.3 Pharmacological and non-
pharmacological treatment
1.4 Prostheses
1.5 Comorbidities and EAM
1.6 Family history of AS
2. Demographics 2.1 Age
2.2 Sex
2.3 Educational and socioeconomic levels
3. Emotional 3.1 Coping with disease
3.2 Quality of life and global well-being
3.3 Social support
4. Life habits 4.1 Smoking
4.2 Current and regular physical activity
5. Occupational 5.1 Absenteeism
5.2 Type of professional activity
5.3 Work environment
6. Socioeconomic 6.1 Unemployment rate
6.2 Social security
6.3 Economic prosperity
6.4 Health care system
WPL, work productivity loss; AS, ankylosing spondylitis; EAM, 
extra-articular manifestations.
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Time since diagnosis
It is not surprising that long-lasting AS symptoms and diag-
nosis delay also contribute to increase the risk of work disabil-
ity.4,6,17,22,27,29-33 The rate of withdrawal from work signifi cantly 
increases for each year of diagnosis – from 5% in the fi rst year 
to 31% for a time since diagnosis longer than 20 years. After 5 
and 15 years of diagnosis, WPL increases from 13% to 23%.18,27
Cakar et al.,31 studying 121 military personnel with AS in 
Turkey, have identifi ed that those with a time since diagnosis 
longer than eight years were more prone to work disability,31 
differently from those with a time since diagnosis shorter 
than fi ve years.30 However, it is worth noting that age at di-
agnosis plays an important role in that assessment.23 Usually, 
the sooner the disease manifests, the greater the chance of 
early disability.8,18,25,34,35
Treatment
Over the past 20 years several therapeutic advances were 
made in the clinical management of patients with AS, such 
as the non-pharmacological (awareness, education, exercises) 
and pharmacological (TNFα inhibitors) approaches, as well as 
advances enabling earlier diagnosis, especially magnetic nu-
clear resonance.21,36-38
Usually, the greater the number of medications used, the 
greater the vulnerability to early withdrawal from the labor 
force, probably related to higher severity and longer duration 
of disease and the presence of concomitant diseases.23
In addition to improving the symptoms and functionality 
of patients with AS, TNFα inhibitors have been recently prov-
en to keep those patients participating in the labor force,38-43 
or even to professionally reassign them in 10% to 25% of the 
cases.20,37,40 The major instruments to assess productive ca-
pacity or reintegration into work are AS-WIS,13 WPAI-SHP,14 
WPAI:SpA15 and WLQ.16
Prostheses
Some studies have shown that even after arthroplasty those 
patients are more prone to abandon their occupational ac-
tivities as compared with those who have not undergone that 
procedure.18,23,31,33 However, it is worth noting that patients un-
dergoing knee or hip  surgery usually have greater functional 
impairment and more severe disease, factors that might con-
found the real dimension of that procedure in the WPL of pa-
tients with AS.
Comorbidities and extra-articular manifestations (EAMs)
Concomitant diseases are more common in patients with 
chronic disorders than in controls. In patients with AS, comor-
bidities are twice more common than in healthy individuals 
(78.7% vs. 31.5%),26,34 being associated with WPL,4,18,23,26,29,32,34 es-
pecially the psychopathological fi ndings, such as anxiety and 
depression.4,22,26,29
The major EAMs related to work disability were peripheral 
arthritis, infl ammatory intestinal disease and uveitis (current 
or previous).5,18,24,28,29,33 
Family history
Some studies have found a signifi cant association between 
family history of AS and WPL.17,32 Forejtová et al.,17 studying 
more than 1,000 patients with AS, have found a history of AS 
in fi rst-degree relatives in 20% of the sample. In addition, they 
had worse health conditions and more disability, according 
to the BASFI and HAQ-DI scales.9 Work productivity loss has 
been attributed to greater disease intensity and severity, as 
well as to the worst prognosis in the family.
Demographics
Age
More advanced age is one of the most important risk factors 
for disability in patients with AS.5,6,21-24,26,28,29,39 On average, pa-
tients with permanent disability are six to ten years older.20 
Thus, the earlier the disease manifests or the later it is diag-
nosed, the higher the risk of early withdrawal from the labor 
force.
In addition, patients with a late diagnosis of AS can retire 
earlier due to their greater diffi culty in adapting to other pro-
fessional activities.8,18,25,34,35
Sex
Studies are controversial regarding sex. Some authors 
have reported that work disability is more common among 
men,6,17,26,27 while others have reported it more commonly 
among women,23,25,28,33,37,39 or even no signifi cant differ-
ence.18,21,29,34 One of the aspects justifying higher WPL among 
men is their greater frequency of structural damage and 
worse axial prognosis.6
Ward and Kuzis, however, have found that women receive 
twice more benefi ts than men, particularly in the fi rst year, 
suggesting that fatigue, pain and limitations are more rele-
vant in the female sex.34
Educational and socioeconomic levels
A higher educational level is positively associated with main-
tenance in the labor force.4,21,23-25,28,32,34,37 Some aspects, such as 
better socioeconomic and educational levels,18,27,34 could ex-
plain that fi nding. In addition, the better capacity to adapt to 
new jobs and compliance with ergonomic managements can 
explain that correlation.25,34
Table 2 – Variables associated with the WPL of patients 
with AS: risk and protective factors.
Risk factors Protective factors
Disease activity Socioeconomic factors
Function Educational factors
Time since diagnosis Coping factors
Concomitant 
medications
Quality of life
Arthroplasty Global well-being 
Associated diseases Social support
Extra-articular 
manifestations
Regular physical activity
Age Less physically-demanding professional 
activities
Smoking Appropriate work environment 
Absenteeism Economic prosperity (lower 
unemployment rate and health care 
system)
Family history of AS Social security system
WPL, work productivity loss; AS, ankylosing spondylitis.
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Emotional
Coping with the disease 
Patients diagnosed with AS usually face disease chronicity, 
experiencing several diffi culties when dealing with functional 
limitation, pain, expectations, dependency, adverse reactions 
to treatment, and prognosis. Those diffi culties can impair 
their well-being and quality of life, interfering with their pro-
ductive capacity.17
In addition, assessing the impact of pain, fatigue and work 
disability on life style, career, family and social life of patients 
with AS is not a simple task, because the magnitude of such 
aspects also relates to the way patients cope with their dis-
eases.4 Coping strategies have been assessed in a study by 
Boonen et al.18 with 658 patients with AS by means of the ‘Cop-
ing with Rheumatic Stressors’ (CORS) questionnaire, which 
measures eight coping styles directed at the disease (three 
related to pain, three related to the limitations on daily activi-
ties, and two related to dependence). Those authors reported 
that the higher the number of coping strategies of patients, 
the greater their capacity to cope with the disease and to keep 
themselves productive at work. In the sample analyzed, 36% 
of the patients had unfavorable scores for those coping strat-
egies, refl ecting more passive attitudes. Thus, the behavioral 
diffi culties of coping with AS represent an elevated risk for 
productive disability.18,23
Barlow et al.,4 in a qualitative approach, have reported 
that patients with AS associate work with economic inde-
pendence as an essential aspect of life, and emphasized 
that their major challenge was to cope with daily fatigue 
and the direct interference with physical, psychic and social 
well-being.
Quality of life and global well-being
Considering that quality of life is the individuals’ perception 
of their position in life in the context of the culture and val-
ue systems in which they live, and in relation to their goals, 
expectations, standards and concerns,44,45 some studies have 
shown the relevant impact of WPL and the worse quality of 
life of patients with AS.25,26 38
The major instruments used to measure quality of life in 
those patients were SF-36 (Medical Outcomes Study short form)46 
and BAS-G (Bath Ankylosing Spondylitis Global health index)47 for 
measuring global well-being, as demonstrated by Chorus et 
al.18,23 Those authors have reported that the worst well-being 
was signifi cantly associated with the early retirement of pa-
tients with AS.
Social support
Social support is considered a protective measure for WPL, 
because it involves the emotional support of friends and fam-
ily in the behavioral reinforcement of better life habits, com-
pliance with treatment, and coping with the disease.22,29
Healthy habits
Smoking
Some studies have demonstrated that the smoking habit is 
a relevant risk factor for WPL.29,32,34 A reduction in the pulmo-
nary and cardiac capacity can interfere directly with the work 
performance of patients with AS,29 and determine a worse re-
sponse to clinical treatment.48
Current physical activity
The practice of physical activity is usually recommended to 
patients with AS. Exercises reduce symptoms, contribute to 
a better posture, improve mobility, help to preserve function, 
and reduce the use of non-steroidal anti-infl ammatory drugs 
(NSAIDs). Thus, those patients become better prepared to per-
form their work activities.17,29,34 
It is worth noting that the regularity and frequency of ex-
ercises are more important than the modality of physical ac-
tivity.17,29,34
Occupational
Absenteeism
Work absenteeism is frequent in patients with AS, particu-
larly in the periods of higher disease activity.25,26 Annually, the 
number of days lost ranges from 8 to 46 days for each patient, 
according to the studies reviewed,5,19,27,37,49 a rate three times 
greater than that observed in the general population.18
According to the prospective study conducted by Ramos-
Remus et al.,21 the absenteeism rate of patients with AS de-
creased over the last 15 years (from 77%, in 1993, to 53%, in 
2007), similarly to the number of lost work days and the pro-
portion of individuals with permanent disability (from 3% to 
2.1%). That illustrates the reduction in the impact of AS on 
productive capacity, probably refl ecting the advance of treat-
ment.21,37,44 Nevertheless, other aspects need to be better ex-
plored, such as fi nancial needs, social health system, educa-
tional level and satisfaction at work.37,50
Type of professional activity
Usually, decisions about the professional career, such as work-
load and type of activity, are individualized and depend on 
each patient’s peculiarities.4,34 In 2001, Barlow et al.4 reported 
that 15% of the patients make professional changes according 
to the AS activity, especially a reduction in worked hours and 
adaptations at the workplace.
For patients with AS, the risk of permanent or temporary 
WPL increases with the increase in physical effort, mainly for 
physically demanding activities (kneeling, reaching, bending, 
crawling), with the increase in manual jobs related to agri-
culture, industry, transport, and civil construction, and with 
excessive worked hours.5,18,25,34 Less physically demanding 
activities, such as administrative and management services, 
help maintaining patients with AS participating in the labor 
force.5,28
Because of the disease, patients with AS engage in more 
passive and sedentary activities, decrease the number of 
hours worked and frequently engage in autonomous activi-
ties. The major negative aspects of such changes relate to loss 
of independence, of self-esteem and of professional satisfac-
tion, and frustrations. However, they can dedicate more time 
to family and treatment.4
Workplace
The work environment most affected by the WPL of patients 
with AS is the industrial sector,23 particularly because of dif-
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fi culties in accessing the workplace,23 ergonomic inadequa-
cy23,51 and lack of cooperation of colleagues34 and superiors.23
Work reconditioning is extremely important as a policy of 
human resources at a fi rm, because about 70% of the patients 
with AS, out of the work force due to the disease, could con-
tinue employed if changes in the work environment had been 
carried out, such as a reduction in monotonous activities that 
impair posture and adjustments in temperature.23
Socioeconomic
When the possibility of early retirement needs to be discussed 
at the workplace, socioeconomic variables, especially the pe-
culiarities of the social security policies, unemployment rates, 
prosperity, and the health system of each country, need to be 
considered.5,20 Boonen et al.5 have reported that disability, ab-
senteeism and the productivity costs of patients with AS are 
higher in the Netherlands than in France and Belgium, due to 
the benefi ts offered by the Dutch government to individuals 
at a prolonged leave of absence. In Denmark, approximately 
30% of the patients with AS are considered permanently dis-
abled for work after 20 years of disease.18 However, that prev-
alence is much lower (13%) in the United States, even for a 
similar disease duration.34
Discussion
The rate of the WPL of patients with AS has varied in different 
studies because of the several factors involved, such as those 
directly inherent in the disease (duration, activity and sever-
ity) and in life habits, and in other aspects, such as demo-
graphics, socioeconomic, psychological, and cultural factors, 
social security, type of work, and the country of residence.
Results regarding sex are controversial. Work productivity 
loss was believed to be more common among men, because 
they are more frequently affected by AS and have a worse 
prognosis as compared with women. However, several au-
thors have reported a higher disability rate among women. 
In addition, compared to men, women receive twice more 
benefi ts due to disability. The major explanations for that fact 
relate to fi nancial, motivational and cultural factors. Appar-
ently, men have a lower chance of permanent work disability, 
because they usually are the family’s fi nancial providers and 
do not easily accept disablement. However, women have in-
creasingly participated more actively in the labor force, more 
often assuming their family’s livelihood and their profession-
al satisfaction, which might make women equally vulnerable 
to WPL.
In addition to the worse prognosis of heredity as a risk fac-
tor for WPL, another hypothesis relates to the apprehended 
behavioral archetype, because the transmission of beliefs, 
values and habits from parents to children induce similar 
thoughts and actions.
Although the higher number of associated diseases and 
of concomitant medications is known to associate with a 
greater likelihood of WPL, their real impact on the work dis-
ability of patients with AS is little known. In addition, which 
health conditions would affect the work disability of patients 
with AS are yet to be fully clarifi ed. Nevertheless, it is worth 
emphasizing that psychological disorders seem to be signifi -
cantly associated, although a causality relationship between 
those events still lacks. Some researchers question whether 
they are consequence of work withdrawal or whether they are 
the actual risk factors. Those fi ndings indicate the need for a 
multiprofessional assessment in that scenario.
To minimize the effect of the occupational variables that 
represent a risk for disability, those patients should be in-
structed to perform tasks that require less physical effort 
and working hours, and partnership among peers should 
be encouraged. In addition, awareness inside the compa-
nies should be encouraged, comprising ergonomic adapta-
tion to the work environment and establishment of human 
resources policy that could meet the need of patients with 
AS, providing them with more autonomy, support and pro-
fessional satisfaction. Another interesting strategy would be 
promoting counseling and professional planning programs 
to guide the career and keep the productive capacity as ad-
equate as possible.
The different criteria for granting benefi ts due to work dis-
ability make the comparison of the work status in different 
countries diffi cult. In addition, the unemployment rates, eco-
nomic prosperity and health care system functioning of each 
country might interfere with the productivity of patients with 
AS, either encouraging or not their participation in the labor 
force. So far, few data have been found to solve or clarify that 
question.
It is worth emphasizing that some results of this review 
should be carefully analyzed, because of limitations, such 
as the diffi culty in accessing rheumatology services, delay 
in diagnosis, heterogeneous characteristics of the different 
populations studied, and the non-adjustment to confound 
factors, as well as the interaction between all those vari-
ables. In addition, those patients are usually discriminated 
and excluded from the major scientifi c studies, even in de-
veloped countries.
Much of the information was obtained from studies that 
considered only the total work disability of withdrawal from 
the offi cial labor force. Many patients are known to have with-
drawn from the labor force due to AS, but continue to unof-
fi cially engage in paid activities, even receiving retirement 
due to disability or sick leave. Similarly, some epidemiological 
studies about risk factors for the WPL of patients with AS have 
a cross-sectional descriptive design, which makes the analy-
sis of the cause-effect relationship of those associations diffi -
cult. Thus, further longitudinal studies are required to assess 
the progression of the predictive variables of WPL of patients 
with AS.
This systematic review of the literature indicates that WPL 
is one of the major consequences of AS. In addition, there are 
variables that can contribute to that phenomenon, such as 
those associated with the disease itself and life habits, and 
those associated with socioeconomic, demographic, emotion-
al, cultural and occupational factors.
The work disability of patients with AS is multifactorial, 
involving not only work loss. Work productivity loss involves 
social, emotional and economic drawbacks that might hinder 
promotion opportunities and cause concern about one’s fu-
ture and autonomy, impairing the quality of life of patients 
with AS.
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